Amylin Proprotein Processing Generates Progressively More Amyloidogenic Peptides that Initially Sample the Helical State
- 19 August 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 47 (37) , 9900-9910
- https://doi.org/10.1021/bi800828u
Abstract
Human amylin, or islet amyloid polypeptide, is a peptide cosecreted with insulin by the beta cells of the pancreatic islets of Langerhans. The 37-residue, C-terminally amidated human amylin peptide derives from a proprotein that undergoes disulfide bond formation in the endoplasmic reticulum and is then subjected to four enzymatic processing events in the immature secretory granule. Human amylin forms both intracellular and extracellular amyloid deposits in the pancreas of most type II diabetic subjects, likely reflecting compromised secretory cell function. In addition, amylin processing intermediates, postulated to initiate intracellular amyloidogenesis, have been reported as components of intracellular amyloid in beta cells. We investigated the amyloidogenicity of amylin and its processing intermediates in vitro. Chaotrope-denatured amylin and amylin processing intermediates were subjected to size exclusion chromatography, affording high concentrations of monomeric peptides. NMR studies reveal that human amylin samples helical conformations. Under conditions mimicking the immature secretory granule (37 °C, pH 6), amylin forms amyloid aggregates more rapidly than its processing intermediates, and more rapidly than its reduced counterparts. Our studies also show that the amyloidogenicity of amylin and its processing intermediates is negatively correlated with net charge and charge at the C-terminus. Although our conditions may not precisely reflect those of amyloidogenesis in vivo, the lower amyloidogenicity of the processing intermediates relative to amylin suggests their presence in intracellular amyloid deposits in the increasingly stressed beta cells of diabetic subjects may be a consequence of general defects in protein homeostasis control known to occur in diabetes rather than serving as amyloid initiators.Keywords
This publication has 49 references indexed in Scilit:
- Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer HypothesisEndocrine Reviews, 2008
- Peptide Conformation and Supramolecular Organization in Amylin Fibrils: Constraints from Solid-State NMRBiochemistry, 2007
- Direct detection of transient α‐helical states in islet amyloid polypeptideProtein Science, 2007
- The Kinetics of Nucleated Polymerizations at High Concentrations: Amyloid Fibril Formation Near and Above the “Supercritical Concentration”Biophysical Journal, 2006
- Destabilization of Human IAPP Amyloid Fibrils by Proline Mutations Outside of the Putative Amyloidogenic Domain: Is There a Critical Amyloidogenic Domain in Human IAPP?Journal of Molecular Biology, 2006
- Prediction of “Aggregation-prone” and “Aggregation-susceptible” Regions in Proteins Associated with Neurodegenerative DiseasesJournal of Molecular Biology, 2005
- Islet amyloid polypeptide: identification of long-range contacts and local order on the fibrillogenesis pathway 1 1Edited by F. CohenJournal of Molecular Biology, 2001
- Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitroBiochemistry, 1995
- β-Structure in Human Amylin and 2 Designer β-Peptides: CD and NMR Spectroscopic Comparisons Suggest Soluble β-Oligomers and the Absence of Significant Populations of β-Strand DimersBiochemical and Biophysical Research Communications, 1994
- A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreasBiochemical and Biophysical Research Communications, 1986